Roodnat J I, van Riemsdijk I C, Mulder P G H, Doxiadis I, Claas F H J, IJzermans J N M, van Gelder T, Weimar W
Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Transplantation. 2003 Jun 27;75(12):2014-8. doi: 10.1097/01.TP.0000065176.06275.42.
The results of living-donor (LD) renal transplantations are better than those of postmortem-donor (PMD) transplantations. To investigate whether this can be explained by a more favorable patient selection procedure in the LD population, we performed a Cox proportional hazards analysis including variables with a known influence on graft survival.
All patients who underwent transplantations between January 1981 and July 2000 were included in the analysis (n=1,124, 2.6% missing values). There were 243 LD transplantations (including 30 unrelated) and 881 PMD transplantations. The other variables included were the following: donor and recipient age and gender, recipient original disease, race, current smoking habit, cardiovascular disease, body weight, peak and current panel reactive antibody, number of preceding transplants and type and duration of renal replacement therapy, and time since failure of native kidneys. In addition, the number of human leukocyte antigen identical combinations, first and second warm and cold ischemia periods, left or right kidney and fossa, donor kidney anatomy, donor serum creatinine and proteinuria, and transplantation year were included.
In a multivariate model, donor origin (PMD vs. LD) significantly influenced the graft failure risk censored for death independently of any of the other risk factors (P=0.0303, relative risk=1.75). There was no time interaction. When the variable cold ischemia time was excluded in the same model, the significance of the influence of donor origin on the graft failure risk increased considerably, whereas the magnitude of the influence was comparable (P=0.0004, relative risk=1.92). The influence of all other variables on the graft failure risk was unaffected when the cold ischemia period was excluded. The exclusion of none of the other variables resulted in a comparable effect. Donor origin did not influence the death risk.
The superior results of LD versus PMD transplantations can be partly explained by the dichotomy in the cold ischemia period in these populations (selection). However, after adjustment for cold ischemia periods, the influence of donor origin still remained significant, independent of any of the variables introduced. This superiority is possibly caused by factors inherent to the transplanted organ itself, for example, the absence of brain death and cardiovascular instability of the donor before nephrectomy.
活体供肾(LD)肾移植的结果优于尸体供肾(PMD)移植。为了研究这是否可以通过LD人群中更有利的患者选择程序来解释,我们进行了Cox比例风险分析,纳入了对移植肾存活有已知影响的变量。
分析纳入了1981年1月至2000年7月期间接受移植的所有患者(n = 1124,缺失值为2.6%)。其中有243例LD移植(包括30例非亲属供肾)和881例PMD移植。纳入的其他变量如下:供体和受体的年龄及性别、受体原发病、种族、当前吸烟习惯、心血管疾病、体重、峰值和当前群体反应性抗体、既往移植次数以及肾脏替代治疗的类型和持续时间,还有自体肾失功后的时间。此外,还纳入了人类白细胞抗原相同组合的数量、首次和第二次热缺血及冷缺血时间、左肾或右肾及肾窝、供肾解剖结构、供体血清肌酐和蛋白尿以及移植年份。
在多变量模型中,供体来源(PMD与LD)独立于任何其他风险因素,对因死亡而截尾的移植肾失功风险有显著影响(P = 0.0303,相对风险 = 1.75)。不存在时间交互作用。在同一模型中排除冷缺血时间变量后,供体来源对移植肾失功风险的影响的显著性大幅增加,而影响程度相当(P = 0.0004,相对风险 = 1.92)。排除冷缺血期后,所有其他变量对移植肾失功风险的影响未受影响。排除其他任何变量均未产生类似效果。供体来源不影响死亡风险。
LD移植与PMD移植相比的优越结果部分可由这些人群冷缺血期的差异(选择)来解释。然而,在对冷缺血期进行调整后供体来源的影响仍然显著,独立于所纳入的任何变量。这种优越性可能是由移植器官本身固有的因素导致的,例如供体在肾切除术前不存在脑死亡和心血管不稳定。